{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:52:51Z","timestamp":1789397571878,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.eplepsyres.2023.107125","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:00:56Z","timestamp":1678831256000},"page":"107125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Investigating anti-inflammatory and immunomodulatory properties of brivaracetam and lacosamide in experimental autoimmune encephalomyelitis (EAE)"],"prefix":"10.1016","volume":"192","author":[{"given":"Oumarou","family":"Ou\u00e9draogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-9655","authenticated-orcid":false,"given":"Renaud","family":"Balthazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Hannah","family":"Mamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Jamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Millette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Daigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Arbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-4782","authenticated-orcid":false,"given":"Catherine","family":"Larochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7878","key":"10.1016\/j.eplepsyres.2023.107125_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.eplepsyres.2023.107125_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3892\/etm.2015.2794","article-title":"Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke","volume":"10","author":"Ahn","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eplepsyres.2018.12.001","article-title":"Intravenous brivaracetam in status epilepticus: correlation between loading dose, plasma levels and clinical response","volume":"149","author":"Aicua-Rapun","year":"2019","journal-title":"Epilepsy Res"},{"issue":"12","key":"10.1016\/j.eplepsyres.2023.107125_bib4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00415-006-0204-1","article-title":"Axonal protection achieved in a model of multiple sclerosis using lamotrigine","volume":"253","author":"Bechtold","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1528-1167.2011.03035.x","article-title":"Antiepileptic drugs and the immune system","volume":"52","author":"Beghi","year":"2011","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2023.107125_bib6","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/brain\/awl216","article-title":"Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE","volume":"129","author":"Black","year":"2006","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.eplepsyres.2023.107125_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1742-7843.2009.00536.x","article-title":"Physiologically based pharmacokinetic\/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy","volume":"106","author":"Brochot","year":"2010","journal-title":"Basic Clin. Pharm. Toxicol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2023.107125_bib8","first-page":"211","article-title":"Use of lacosamide in children with refractory epilepsy","volume":"17","author":"Buck","year":"2012","journal-title":"J. Pedia Pharm. Ther."},{"issue":"5","key":"10.1016\/j.eplepsyres.2023.107125_bib9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/eji.200323492","article-title":"Effective and selective immune surveillance of the brain by MHC class I\u2010restricted cytotoxic T lymphocytes","volume":"33","author":"Cabarrocas","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174696","article-title":"Anti-inflammatory properties of lacosamide in an astrocyte-microglia co-culture model of inflammation","volume":"915","author":"Corvace","year":"2022","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virol.2012.09.012","article-title":"Anti-viral CD8 T cells and the cytokines that they love","volume":"435","author":"Cox","year":"2013","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.eplepsyres.2023.107125_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/epi.12973","article-title":"Anti\u2010ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats","volume":"56","author":"Dupuis","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107125_bib13","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.121.000585","article-title":"Therapeutic effects of time-limited treatment with brivaracetam on posttraumatic epilepsy after fluid percussion injury in the rat","author":"Eastman","year":"2021","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib14","first-page":"12","article-title":"Diazepam impairs innate and adaptive immune responses and ameliorates experimental autoimmune encephalomyelitis","author":"Falc\u00f3n","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2023.107125_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/1567202617666200514114917","article-title":"Brivaracetam prevents the over-expression of synaptic vesicle protein 2A and rescues the deficits of hippocampal long-term potentiation in vivo in chronic temporal lobe epilepsy rats","volume":"17","author":"Ge","year":"2020","journal-title":"Curr. Neurovasc Res"},{"key":"10.1016\/j.eplepsyres.2023.107125_bib16","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/NDT.S256699","article-title":"Clinical management of drug resistant epilepsy: a review on current strategies","volume":"17","author":"Guery","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.eplepsyres.2023.107125_bib17","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/epi.16500","article-title":"Influence of dose and antiepileptic comedication on brivaracetam serum concentrations in patients with epilepsy","volume":"61","author":"Hagemann","year":"2020","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"10.1016\/j.eplepsyres.2023.107125_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2001.00008.x","article-title":"Safety profile of levetiracetam","volume":"42","author":"Harden","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107125_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/806162","article-title":"Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro","volume":"2014","author":"Himmerich","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000495425","article-title":"Targeting voltage-dependent calcium channels with pregabalin exerts a direct neuroprotective effect in an animal model of multiple sclerosis","volume":"26","author":"Hundehege","year":"2018","journal-title":"Neurosignals"},{"issue":"Supplement_1","key":"10.1016\/j.eplepsyres.2023.107125_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcab114","article-title":"Neuroprotective effect of lacosamide on cognitive dysfunction in Streptozotocin induced Alzheimer disease","volume":"114","author":"Ibrahim","year":"2021","journal-title":"QJM: Int. J. Med."},{"issue":"12","key":"10.1016\/j.eplepsyres.2023.107125_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10529-019-02743-w","article-title":"Comparison of two commonly used methods for stimulating T cells","volume":"41","author":"Jiao","year":"2019","journal-title":"Biotechnol. Lett."},{"issue":"10","key":"10.1016\/j.eplepsyres.2023.107125_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11310900-000000000-00000","article-title":"Seizures in patients with multiple sclerosis","volume":"23","author":"Kelley","year":"2009","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.eplepsyres.2023.107125_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: rationale for discovery and preclinical profile of a selective SV 2A ligand for epilepsy treatment","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2023.107125_bib25","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s12272-011-1208-7","article-title":"Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats","volume":"34","author":"Koo","year":"2011","journal-title":"Arch. Pharm. Res."},{"issue":"10","key":"10.1016\/j.eplepsyres.2023.107125_bib26","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1093\/brain\/aws212","article-title":"Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system","volume":"135","author":"Larochelle","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.24415","article-title":"Melanoma cell adhesion molecule\u2013positive CD 8 T lymphocytes mediate central nervous system inflammation","volume":"78","author":"Larochelle","year":"2015","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1352458516641775","article-title":"Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal","volume":"23","author":"Larochelle","year":"2017","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03186-z","article-title":"EGFL7 reduces CNS inflammation in mouse","volume":"9","author":"Larochelle","year":"2018","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.eplepsyres.2023.107125_bib30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0000000000002545","article-title":"Brivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis","volume":"86","author":"Lattanzi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2023.107125_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneumeth.2015.03.021","article-title":"An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry","volume":"247","author":"Legroux","year":"2015","journal-title":"J. Neurosci. Methods"},{"issue":"6","key":"10.1016\/j.eplepsyres.2023.107125_bib32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.seizure.2013.03.006","article-title":"Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes","volume":"22","author":"Li","year":"2013","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.eplepsyres.2023.107125_bib33","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/epi.12196","article-title":"Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model","volume":"54","author":"Licko","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107125_bib34","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopha.2017.11.066","article-title":"Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis","volume":"96","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.imbio.2018.10.004","article-title":"PHA eludes macrophage suppression to activate CD8(+) T cells","volume":"224","author":"Lomakova","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.eplepsyres.2023.107125_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106985","article-title":"Evaluation of psychomotor functions in patients with drug-resistant epilepsy","volume":"106","author":"Mathon","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms23147671","article-title":"Levetiracetam suppresses the infiltration of neutrophils and monocytes and downregulates many inflammatory cytokines during epileptogenesis in pilocarpine-induced status epilepticus mice","volume":"23","author":"Matsuo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.eplepsyres.2023.107125_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/epi.13267","article-title":"Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action","volume":"57","author":"Nicolas","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","article-title":"Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/epi.16742","article-title":"Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy","volume":"62","author":"Ou\u00e9draogo","year":"2021","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.eplepsyres.2023.107125_bib41","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/glia.22967","article-title":"Sodium channels in astroglia and microglia","volume":"64","author":"Pappalardo","year":"2016","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2023.107125_bib42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1517\/14656566.5.4.777","article-title":"Antiepileptic drugs in neuroprotection","volume":"5","author":"Pitk\u00e4nen","year":"2004","journal-title":"Expert Opin. Pharm."},{"issue":"3","key":"10.1016\/j.eplepsyres.2023.107125_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Raftopoulos","year":"2016","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2147\/DDDT.S154388","article-title":"\"Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines","volume":"12","author":"Reimers","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-017-0546-9","article-title":"In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells","volume":"36","author":"Rizzo","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2014.11.021","article-title":"Current understanding of the mechanism of action of the antiepileptic drug lacosamide","volume":"110","author":"Rogawski","year":"2015","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2008.03158.x","article-title":"The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men","volume":"66","author":"Rolan","year":"2008","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yebeh.2017.11.019","article-title":"Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model","volume":"79","author":"Sanon","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/epd.2012.0493","article-title":"Patients with generalised epilepsy have a higher white blood cell count than patients with focal epilepsy","volume":"14","author":"Sarkis","year":"2012","journal-title":"Epileptic Disord."},{"issue":"3","key":"10.1016\/j.eplepsyres.2023.107125_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eplepsyres.2011.03.019","article-title":"Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions--first clinical experience","volume":"95","author":"Sattler","year":"2011","journal-title":"Epilepsy Res."},{"issue":"6","key":"10.1016\/j.eplepsyres.2023.107125_bib52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00228-017-2230-6","article-title":"Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years","volume":"73","author":"Schoemaker","year":"2017","journal-title":"Eur. J. Clin. Pharm."},{"issue":"7","key":"10.1016\/j.eplepsyres.2023.107125_bib53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/epi.12237","article-title":"Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice","volume":"54","author":"Shandra","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2023.107125_bib54","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/brb3.276","article-title":"Impact of pregabalin treatment on synaptic plasticity and glial reactivity during the course of experimental autoimmune encephalomyelitis","volume":"4","author":"Silva","year":"2014","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"10172","key":"10.1016\/j.eplepsyres.2023.107125_bib56","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.intimp.2012.05.021","article-title":"Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis","volume":"14","author":"Th\u00f6ne","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.eplepsyres.2023.107125_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919886503","article-title":"Brivaracetam attenuates pain behaviors in a murine model of neuropathic pain","volume":"15","author":"Tsymbalyuk","year":"2019","journal-title":"Mol. Pain."},{"issue":"11","key":"10.1016\/j.eplepsyres.2023.107125_bib59","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.bcp.2011.03.010","article-title":"Plant lectins are novel Toll-like receptor agonists","volume":"81","author":"Unitt","year":"2011","journal-title":"Biochem. Pharm."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI132531","article-title":"Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity","volume":"130","author":"Wagner","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.eplepsyres.2023.107125_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12028-012-9808-8","article-title":"Lacosamide improves outcome in a murine model of traumatic brain injury","volume":"19","author":"Wang","year":"2013","journal-title":"Neurocrit Care"},{"issue":"9","key":"10.1016\/j.eplepsyres.2023.107125_bib62","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s10072-020-04360-2","article-title":"Effect of phenytoin on retinal ganglion cells in acute isolated optic neuritis","volume":"41","author":"Yadegari","year":"2020","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.eplepsyres.2023.107125_bib63","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/bcp.13296","article-title":"Do antiepileptic drugs increase the risk of infectious diseases? A meta\u2010analysis of placebo\u2010controlled studies","volume":"83","author":"Zaccara","year":"2017","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121123000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121123000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:49:57Z","timestamp":1760276997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121123000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":63,"alternative-id":["S0920121123000505"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107125","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating anti-inflammatory and immunomodulatory properties of brivaracetam and lacosamide in experimental autoimmune encephalomyelitis (EAE)","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107125"}}